ELOVL6 and atherosclerosis: Elovl6 knockout mice showed a marked resistant to diet-induced hyperinsulinemia, atherosclerosis, and steatohepatitis presumably due to the altered fatty acid composition in the liver and macrophages, respectively [5–7].